When you spend a lot of time in doctors’ offices and waiting rooms, you start to realize how many people and how much training it takes to keep one person healthy. None of that happens by accident. It ...

Arexera Therapeutics plans to launch a Phase 1 trial testing its experimental treatment ATL-101 in Huntington's patients ...

The experimental therapy brezosiran can reduce levels of the mutant huntingtin protein in people with Huntington’s disease, according to interim data from a small clinical trial. The results were ...

There is something powerful about standing in a room and telling the truth about what it means to live with Huntington’s disease (HD). Every time I share my story, I am reminded that advocacy is not ...

In the quiet, not-so-often-seen life of a Huntington’s disease (HD) caregiver, there is a commonality among them that even they may not realize. Even within this quiet corner of the HD community, it ...

My wife, Jill, who is gene-positive with Huntington’s disease (HD), told me recently that she has to “pump herself up” to do almost anything now. It’s not just the big things, like medical ...

Carlos Briceño is a journalist and director of communications who, through the grace of God, has been blessed with a brilliant, beautiful, and courageous wife and daughter. He currently lives in ...

Blake Sauls serves as a dedicated caregiver and advocate with HD Reach, supporting his wife, Wendy, who is a Huntington’s Disease Warrior. Born and raised in Wilson, N.C., Blake and Wendy have been ...

There is no cure for Huntington’s disease, nor have any disease-modifying therapies been developed yet that can stop its progression. However, there are approved treatments that can help patients ...

Atalanta Therapeutics has raised $97 million to support planned Phase 1 clinical trials of its experimental RNA interference (RNAi)-based therapies for Huntington’s disease and a genetic form of ...

Years ago, my wife, Jill, was at a party talking with a friend. The conversation turned personal, and her friend asked a difficult question. It was the kind of question people sometimes ask when they ...

A Phase 1 trial will evaluate PTC Therapeutic’s PTC518, its investigational therapy for Huntington’s disease, in healthy volunteers, the company announced. The trial’s first results are expected in ...